Screening High-Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists
- PMID: 29426066
- PMCID: PMC5984667
- DOI: 10.1002/art.40441
Screening High-Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists
Figures
Comment in
-
Reply.Arthritis Rheumatol. 2019 Feb;71(2):327-328. doi: 10.1002/art.40762. Epub 2018 Dec 29. Arthritis Rheumatol. 2019. PMID: 30346112 No abstract available.
-
Using High-Resolution Computed Tomography to Detect Interstitial Lung Disease in Patients With Systemic Sclerosis: Comment on the Concise Communication by Bernstein et al.Arthritis Rheumatol. 2019 Feb;71(2):327. doi: 10.1002/art.40763. Epub 2019 Jan 9. Arthritis Rheumatol. 2019. PMID: 30346662 No abstract available.
References
-
- Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69:1809–15. - PubMed
-
- Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, et al. Brief report: Pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol. 2015;67:3256–61. - PubMed
-
- Steen VD, Conte C, Owens GR, Medsger TA., Jr Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum. 1994;37:1283–9. - PubMed
-
- Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006;354:2655–66. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
